Kiromic BioPharma (KRBP) News Today → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free KRBP Stock Alerts $3.08 +0.32 (+11.59%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 3:00 AM | americanbankingnews.comKiromic BioPharma (NASDAQ:KRBP) Trading 3.4% Higher May 13, 2024 | investorplace.comKRBP Stock Earnings: Kiromic BioPharma Reported Results for Q1 2024May 13, 2024 | americanbankingnews.comKiromic BioPharma (NASDAQ:KRBP) Posts Quarterly Earnings ResultsApril 26, 2024 | uk.investing.comDeltacel shows promise in Kiromic BioPharma lung cancer trial, Kiromic seeks FDA fast trackApril 24, 2024 | finance.yahoo.comKiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three PatientsApril 10, 2024 | msn.comKiromic BioPharma files to withdraw registration statementApril 2, 2024 | businesswire.comKiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical TrialMarch 19, 2024 | finance.yahoo.comEarly Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical TrialMarch 19, 2024 | businesswire.comEarly Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical TrialMarch 1, 2024 | businesswire.comKiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialFebruary 28, 2024 | finance.yahoo.comKiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7thFebruary 28, 2024 | businesswire.comKiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7thFebruary 14, 2024 | finance.yahoo.comResults from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two MonthsFebruary 14, 2024 | businesswire.comResults from First Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two MonthsJanuary 29, 2024 | finance.yahoo.comKiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerJanuary 5, 2024 | finance.yahoo.comKiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical TrialDecember 14, 2023 | finance.yahoo.comKiromic BioPharma Announces First Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung CancerNovember 16, 2023 | finance.yahoo.comKiromic BioPharma Announces Uplisting to OTCQB MarketNovember 9, 2023 | finance.yahoo.comKiromic BioPharma Announces Deltacel™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer CenterNovember 1, 2023 | morningstar.comKiromic BioPharma Inc Ordinary SharesOctober 23, 2023 | finance.yahoo.comKiromic BioPharma and Beverly Hills Cancer Center Enter Clinical Trial AgreementSeptember 15, 2023 | uk.investing.comStaidson Beijing Biopharma (300204)September 13, 2023 | finance.yahoo.comKiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14July 24, 2023 | finance.yahoo.comKiromic BioPharma Welcomes Two New Directors to its BoardJuly 12, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 09:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 09:07 AM with a stated reason of "LULD pause."June 30, 2023 | marketwatch.comKiromic Biopharma Shares Down 12% After Stock Offering ProspectusJune 10, 2023 | bizjournals.comFounder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing roundJune 10, 2023 | finance.yahoo.comKRBP - Kiromic BioPharma, Inc.June 8, 2023 | theglobeandmail.comInstrument Name Kiromic Biopharma Inc Instrument Symbol (KRBP-Q)May 22, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 12:05 PM with a stated reason of "LULD pause."May 10, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 01:05 PM with a stated reason of "LULD pause."May 8, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 03:05 PM with a stated reason of "LULD pause."May 8, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 02:05 PM with a stated reason of "LULD pause." Trading set to resume at 02:05 PM. May 4, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 11:05 AM with a stated reason of "LULD pause."May 3, 2023 | finance.yahoo.comWhat's Going On With Kiromic BioPharma Stock WednesdayMay 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 03:05 PM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 11:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 11:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 1, 2023 | finance.yahoo.comKiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung CancerApril 17, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 09:04 AM with a stated reason of "LULD pause."April 13, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:04 AM with a stated reason of "LULD pause."April 3, 2023 | finance.yahoo.comKiromic BioPharma Submits Investigational New Drug Application for Phase 1 Trial with Deltacel for Non-Small Cell Lung CancerMarch 31, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:03 AM with a stated reason of "LULD pause." Get Kiromic BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Invest in the "Trojan Horse" of Alzheimer's Treatment (Ad)This one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics. Click here and learn how you can invest in this incredible opportunity>>> KRBP Media Mentions By Week KRBP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRBP News Sentiment▼0.490.54▲Average Medical News Sentiment KRBP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRBP Articles This Week▼50▲KRBP Articles Average Week Get Kiromic BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FNCH News Today ALBT News Today ELOX News Today TCON News Today WINT News Today FRTX News Today TTNP News Today CELZ News Today PALI News Today IKT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRBP) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe Exchange[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiromic BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
